Introduction
============

The orthodenticle protein homolog 2 (*OTX2*) is a homeobox gene that plays a critical role in retinal photoreceptor development. The gene, on chromosome 14q23.1, is organized into five exons, only three of which are translated. It contains a highly conserved homeodomain. *OTX2* is expressed during development in the neuroepithelium of most of the forebrain and midbrain, including the eye domain \[[@r1]\]. Complete elimination of *OTX2* function in mice by gene targeting results in the absence of the forebrain and embryonic lethality \[[@r2],[@r3]\]. While *Otx2* null embryos display a severe cranial phenotype, lacking the anterior neuroectoderm, and with abnormalities in body plan \[[@r2],[@r3]\], heterozygous deletion of *Otx2* leads to a variable phenotype that is dependent on genetic background. *Otx2*^+/−^ mice can be normal, have developmental eye anomalies including anterior segment malformations, severe eye abnormalities such as microphthalmia or anophthalmia, or head abnormalities \[[@r2],[@r4]\]. In early development *Otx2*, specifies the anterior neuroectoderm during gastrulation \[[@r2]\] and is expressed throughout the forebrain and midbrain in the developing embryo \[[@r1]\]. Once eye development is specified, expression of *Otx2* narrows. It is required for the development of the presumptive retinal pigment epithelium (RPE) \[[@r5]\], where it has a continuing maintenance role throughout adulthood \[[@r6]\]. Analysis of *Otx2*^−/−^ mice has shown that it is essential for specification of the RPE; loss of OTX2 function results in the outer layer of the optic cup developing into ectopic neural retina \[[@r7]\]. However, OTX2 is also required for the development and maintenance of the neural retina. Otx2 protein is found in bipolar and in ganglion cells \[[@r6],[@r8],[@r9]\], while in the outer nuclear layer it regulates the expression of the closely related *Crx* gene that controls the expression of a suite of photoreceptor function genes, including opsins. Otx2 and Crx can also bind to common DNA-binding sequences \[[@r10]\]. Ablation of *OTX2* in retinal progenitor cells has been shown to affect RPE development and leads to a significant decrease in rod photoreceptors and bipolar cells, suggesting that OTX2 is also involved in retinal bipolar cell development \[[@r8]\]. It has recently been demonstrated that OTX2 protein is transported from the retina to the visual cortex in the developing rat, and appears to modify postnatal synaptic plasticity \[[@r9]\].

*OTX2* mutations in humans have been associated with a range of ophthalmological phenotypes including anophthalmia, microphthalmia, developmental anomalies of the optic nerve and chiasm, and Leber congenital amaurosis (LCA). As OTX2 plays a key role in retinal development, and a mutation in *OTX2* has been reported in association with an infantile onset retinal dystrophy \[[@r11]\], we screened a large panel of patients with LCA and other forms of childhood onset retinal dystrophy for mutations in this gene.

Methods
=======

A panel of DNA from 142 patients with LCA and severe childhood onset retinal dystrophy were recruited at Moorfields Eye Hospital and The Hospital for Children, Great Ormond Street, London, as part of an ongoing molecular genetic study of childhood retinal dystrophies. The research has local research ethics committee approval and conformed to the tenets of the Declaration of Helsinki. A full clinical history was taken and examination performed in all subjects. In older children and adults this included, where possible, best corrected logMAR visual acuity and color vision (Hardy Rand Rittler, Richmond Products, Albuquerque, NM); slit-lamp biomicroscopy or indirect ophthalmoscopy; Goldmann visual fields; autorefraction (Luneau L62--3D autorefractokeratometer - LUNEAU Chartres, France), axial length measurement, and auto-keratometry (IOL Master, Carl Zeiss Meditec, Dublin, CA); optical coherence tomography (Stratus OCT™ - software version 3; Carl Zeiss Meditec, Inc.); fundus photography (TRC-50IX with IMAGEnet 2000 system software--TOPCON Corporation, Japan), and fundus autofluorescence (Heidelberg Retinal Angiograph-II, Heidelberg Engineering, Heidelberg, Germany). All patients had electroretinography performed either at our institutions or at the referring hospital. Most patients had tests performed at diagnosis which, in the older patients, predated the ISCEV standards. Patients seen more recently, or in whom we wished to confirm the diagnosis, had electroretinography conducted in accordance with current International Society for Clinical Electrophysiology of Vision standards using gold foil or DTL electrodes \[[@r12],[@r13]\]. ERG testing in infants and young children was performed using skin electrodes in accordance with previously published protocols \[[@r14],[@r15]\].

DNA was extracted from whole blood obtained from each affected individual and immediate family members using the Nucleon BACC-2 kit (GE Healthcare) performed as per manufacturer's instructions. DNA samples from all patients were sent to Asper Ophthalmics (Tartu, Estonia) for analysis using the LCA chip \[[@r16]\]. This is a microarray which contained (at the time of the study) 344 disease associated SNPs and several common variant polymorphisms in six LCA associated genes and 2 early onset genes (*GUCY2D, CRX, RPE65, CRB1, RPGRIP1, AIPL1, LRAT,* and *MERTK*). Genorama genotyping software (Asper Ophthalmics Ltd) can subsequently produce a bidirectional allele call at each SNP being interrogated. The panel subsequently underwent direct sequencing of PCR products \[[@r11]\] performed using an ABI 3130 36 cm capillary sequencer (Applied Biosystems, Inc., Foster City, CA). 181 control DNA samples isolated from anonymous Aberdeen-based blood donors were screened for DNA mismatches using the Idaho Technology Inc. Light Scanner (Salt Lake City, UT). Fragments revealing a nucleotide mismatch were fully sequenced to identify the mutations.

Results
=======

A de novo heterozygous c.413C\>G p.S138X stop mutation was identified in a seven-year-old male ([Figure 1](#f1){ref-type="fig"}; Pt 13424) who was negative for all variants assayed by the LCA chip. The mutation was not present in either parent. This mutation was not detected in 181 controls. Known polymorphic single nucleotide polymorphisms (SNPs), were observed at similar frequencies in the disease cohort and the blood donor controls, indicating that the ethnic background of the patient cohort and the controls was comparable.

![Direct sequencing. At the position indicated by the black arrowhead, the heterozygous C\>G change is revealed in the DNA sequence trace for patient NH13424. Below this the wild type trace for normal control subject DIFIG is shown.](mv-v15-2442-f1){#f1}

The patient had a history of failure to thrive from birth and multiple investigations of the possible cause including investigations for Batten disease, Williams syndrome, and Russell-Silver dwarfism, all of which were negative. At 9 months old, required nasogastric feeding for 6 months following a history of failure to thrive. He has always been on the lowest percentiles for stature. Growth hormone deficiency was suggested indirectly via low levels of IGF1 and IGFBP3. An MRI scan was reported as normal. His parents noted poor vision and nyctalopia during his first year of life. There was no family history of eye disease. One younger sibling who has no visual problems was unavailable for further investigation.

Ophthalmic examination when he was six years old disclosed a small angle alternating esotropia with mild torsional nystagmus. Visual acuities were 0.4 and 0.5 logMAR in his right and left eyes, respectively. Cycloplegic retinoscopy revealed a refractive error of 0.00 diopter sphere/+3.00 diopter cylinder at 180 degrees in the right eye, and +3.00 diopter sphere /+2.50 diopter cylinder at 180 degrees in the left. He had normal color vision, according to Hardy Rand Rittler; he had normal pupil reactions and clear lenses. Funduscopy revealed a hyperpigmented area of retina surrounding the optic disc with a fine granular pigmentation of the RPE throughout the fundus ([Figure 2](#f2){ref-type="fig"}). There was no vascular attenuation.

![Fundus photography. Images are right and left eye color fundus photograph composites of patient NH13424 performed using TOPCON retinal camera at 2.45x magnification at 35 degrees. Composite images were created using Adobe Photoshop. Image cropping and reflections are observed secondary to poor pupil dilatation. The images show significant and abnormal peripapillary hyperpigmentation with fine granular pigmentation at the level of the retinal pigment epithelium (RPE).](mv-v15-2442-f2){#f2}

ERGs were performed according to international standards \[[@r13]\]. The dark-adapted bright flash ERG was markedly electronegative with additional a-wave reduction. Light-adapted flicker ERGs were delayed and subnormal and the single flash cone ERG was subnormal with a reduced b:a ratio ([Figure 3](#f3){ref-type="fig"}). The profoundly negative ERG suggests dysfunction that is both marked and at a level that is post-phototransduction, usually post-receptoral. The a-wave was subnormal but not delayed, indicating additional loss of photoreceptor function. The ON-OFF and S-cone ERGs \[[@r17],[@r18]\] suggesting greater ON- than OFF- bipolar pathway involvement. The pattern ERG P50 component was reduced bilaterally, which is consistent with macular involvement. ([Figure 3](#f3){ref-type="fig"})

![Electrophysiology. Full-field ERGs and pattern ERGs from the right (row 1) and left eye (row 2) of the patient and normal examples (row 3) for comparison. Full-field ERGs were performed using corneal electrodes in August 2007; pattern ERGs had been recorded to a 30 degree field checkerboard stimulus using periorbital surface electrodes two years earlier. Dark-adapted ERGs are shown for flash intensities of 0.01 and 11.5 cd.s.m^−2^; light-adapted ERGs for a flash intensity of 3.0 cd.s.m^−2^ at 30 Hz (flicker) and at 2 Hz.. ON-OFF ERGs used an orange stimulus (560 cd.m^−2^, duration 200 ms) superimposed on a green background (150 cd.m^−2^). S-cone ERGs used a blue stimulus (445 nm, 80 cd.m^−2^) on an orange background (620 nm, 560 cd.m^−2^). Eye movement artifacts are replaced by broken lines for clarity. S-cone ERGs were unavailable for the right eye.](mv-v15-2442-f3){#f3}

Discussion
==========

This study provides evidence of a novel mutation in OTX2 associated with early onset retinal dystrophy and pituitary insufficiency. This mutation is predicted to lead a truncated protein. Chatelain et al. \[[@r19]\] observed that OTX2 truncation at residues 106 and 161, flanking the site of the predicted termination, described here, leads to loss of transactivation function. This strongly suggests that the mutation identified in our patient is also likely to cause haploinsufficiency.

Clinical studies have demonstrated that mutations in *OTX2* are associated with a wide range of ocular phenotypes ([Table 1](#t1){ref-type="table"}) \[[@r7],[@r11],[@r20]--[@r22]\]. Experimentally, the role of *OTX2* in regional specification of the eye, particularly the RPE, has long been established from expression studies in normal and mutant animal models \[[@r1],[@r4],[@r23]--[@r26]\]. Subsequent studies have also demonstrated the role of *OTX2* in the development of both the retinal photoreceptors and bipolar cells \[[@r25],[@r27]\]. It has been hypothesized that *OTX2* is involved in retinal photoreceptor cell fate but not in bipolar cell fate in early development, while it is involved in the terminal differentiation of both photoreceptors and bipolar cells late in development in cooperation with *CRX* \[[@r8]\]. Pituitary dysfunction has been described in two patients with heterozygous 14q22--23 microdeletions involving *OTX2* \[[@r28],[@r29]\]. Recently, the role of OTX2 in pituitary development has been further delineated with three case reports of *OTX2* mutations associated with pituitary hormone deficiency (CPHD) \[[@r21],[@r22]\]. A further case of anophthalmia associated with an *OTX2* mutation was reported to have isolated growth hormone deficiency and short stature \[[@r7]\]. In the latter publication a requirement for OTX2 binding was postulated at a site previously shown to lie in the promoter of HESX1 \[[@r30]\].

###### Previously published mutations in *OTX2* with associated phenotypes.

  **Nucleotide**        **Protein**           **Phenotype**                                                                  **Reference**
  --------------------- --------------------- ------------------------------------------------------------------------------ ---------------
  c.674A\>G             p.Asn225Ser           CPHD                                                                           \[[@r22]\]
  c.674A\>G             p.Asn225Ser           CPHD                                                                           \[[@r22]\]
  whole gene deletion   whole gene deletion   Extreme microphthalmia                                                         \[[@r20]\]
  whole gene deletion   whole gene deletion   Anophthalmia                                                                   \[[@r20]\]
  c.93C\>G              p.Tyr31X              Microphthalmia                                                                 \[[@r20]\]
  c.106dupC             p.Arg36ProfsX52       Microphthalmia OD/ normal OS                                                   \[[@r20]\]
  c.106dupC             p.Arg36ProfsX52       Anophthalmia OD/ Coloboma OS                                                   \[[@r20]\]
  c.289C\>T             p.Gln97X              Extreme microphthalmia                                                         \[[@r20]\]
  c.289C\>T             p.Gln97X              Inferior iris coloboma OD/ retinal coloboma OS                                 \[[@r20]\]
  c.373_374delAG        p.Gly126TrpfsX11      Anophthalmia                                                                   \[[@r20]\]
  c.404_405dupCT        p.Ser136LeufsX43      Anophthalmia and CPHD                                                          \[[@r21]\]
  c.402dupC             p.Ser135LeufsX2       Anophthalmia, GH deficiency; cleft palate                                      \[[@r7]\]
  c.463_464dupGC        p.Ser156LeufsX23      bilateral anophthalmia; developmental delay                                    \[[@r11]\]
  c.265C\>G             p.Arg89Gly            bilateral microphthalmia                                                       \[[@r11]\]
  c.81delC              p.Ser28ProfsX23       bilateral severe microphthalmia                                                \[[@r11]\]
  c.537T\>A             p.Tyr179X             severe microphthalmia and colobomata, developmental delay seizures             \[[@r11]\]
  c.537T\>A             p.Tyr179X             bilateral mild microphthalmia, retinal dystrophy originally described as LCA   \[[@r11]\]
  c.117_118delCC        p.Arg40GlyfsX47       bilateral anophthalmia                                                         \[[@r11]\]
  c.295C\>T             p.Gln99X              bilateral anopthalmia                                                          \[[@r11]\]
  c.397C\>A             p.Pro133Thr           bilateral microphthalmia                                                       \[[@r11]\]
  c.400C\>G             p.Pro134Ala           anophthalmia OS/ OD normal                                                     \[[@r11]\]

Mutations in *OTX2*. a summary of the published cases. Table lists previously published mutations in *OTX2* with associated phenotypes. The nucleotide and protein nomenclature used conforms to current standards and may differ from the notation used in the original publications ([LOVD](http://lsdb.hgu.mrc.ac.uk/home.php?select_db=OTX2)). Abbreviations: CPHD represents combined pituitary hormone deficiency; OD represents right eye; OS represents left eye; GH represents growth hormone.

The phenotypic spectrum described in this case report is consistent with the assigned multiple roles of *OTX2* in the development and function of both RPE and neural retinal, as well as in the pituitary. Mutations in *OTX2* are a rare cause of infantile onset retinal dystrophies and the finding of an electronegative ERG with additional a-wave reduction suggests that there is dysfunction at the level of the photoreceptor and also post-phototransduction, likely to involve both ON- and OFF- bipolar cells. Funduscopy revealed a fine granular pigmentation of the RPE. In addition, an unusual hyperpigmented juxtapapillary ring, not normally seen in retinal dystrophies, was observed. The history of early failure to thrive and subsequent short stature with low implied growth hormone levels adds further support for a role for *OTX2* in pituitary function.
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